A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : p-AKT

Search Conditions:
Search Keyword : p-AKT
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 3 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: p-AKT
Appearance Frequency: 439 time(s)
Long forms: 19

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
phosphorylated AKT
(265 times)
Neoplasms
(92 times)
PI3K (49 times)
EGFR (19 times)
p-mTOR (14 times)
2004 Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor.
phospho-AKT
(69 times)
Neoplasms
(28 times)
PI3K (14 times)
p-mTOR (8 times)
mTOR (7 times)
2004 Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
phospho-protein kinase B
(43 times)
Neoplasms
(7 times)
P-mTOR (11 times)
PI3K (9 times)
Bcl-2 (5 times)
2008 [Effects of ischemia postconditioning on ischemia-reperfusion injury and reperfusion injury salvage kinase signal transduction pathways in isolated mouse hearts].
phosphorylation of AKT
(32 times)
Neoplasms
(8 times)
PI3K (7 times)
ER (3 times)
COPD (2 times)
2009 Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.
phosphorylated serine/threonine kinase
(11 times)
Medicine
(3 times)
PI3K (4 times)
p-PI3K (3 times)
NF-kappaB (2 times)
2008 Increased pancreatic islet mass is accompanied by activation of the insulin receptor substrate-2/serine-threonine kinase pathway and augmented cyclin D2 protein levels in insulin-resistant rats.
phosphor-AKT
(4 times)
Neoplasms
(2 times)
AKT (1 time)
CAM (1 time)
CAT (1 time)
2016 MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma.
p-protein kinase B
(2 times)
Biochemistry
(1 time)
CCK-8 (1 time)
DEX (1 time)
EGFR (1 time)
2019 Interaction between epidermal growth factor receptor and interleukin-6 receptor in NSCLC progression.
phosphorylated ATP-dependent tyrosine kinase
(2 times)
Neoplasms
(1 time)
AR_H460 (1 time)
Bcl-2 (1 time)
Cdc42 (1 time)
2016 Renieramycin M Sensitizes Anoikis-resistant H460 Lung Cancer Cells to Anoikis.
patterns, but there was hyperactivation of AKT
(1 time)
Neoplasms
(1 time)
--- 2013 Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
10  pGz increased Akt phosphorylation
(1 time)
Biochemistry
(1 time)
--- 2009 In vivo upregulation of nitric oxide synthases in healthy rats.
11  phosphatized AKT
(1 time)
Neoplasms
(1 time)
DFS (1 time)
EGFR (1 time)
ER (1 time)
2007 [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
12  phospho-Ser473-AKT
(1 time)
Neoplasms
(1 time)
p-Src (1 time)
2017 Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.
13  phosphorylated AKT kinase
(1 time)
Radiology
(1 time)
IR (1 time)
PCNA (1 time)
2006 Radiation-induced molecular changes in rat mammary tissue: possible implications for radiation-induced carcinogenesis.
14  phosphorylation status of AKT
(1 time)
Cell Biology
(1 time)
CXCR4 (1 time)
DFO (1 time)
HIF-1alpha (1 time)
2018 Deferoxamine promotes mesenchymal stem cell homing in noise-induced injured cochlea through PI3K/AKT pathway.
15  protein and a 21-53% drop in active AKT kinase
(1 time)
Cell Biology
(1 time)
--- 2015 MicroRNA-126 suppresses proliferation of undifferentiated (BRAF(V600E) and BRAF(WT)) thyroid carcinoma through targeting PIK3R2 gene and repressing PI3K-AKT proliferation-survival signalling pathway.
16  protein kinase B phosphorylation
(1 time)
Biochemistry
(1 time)
PIC (1 time)
PR (1 time)
TRAF2 (1 time)
2013 Blockage of progesterone receptor effectively protects pancreatic islet beta cell viability.
17  protein-serine-threonine kinase
(1 time)
Stem Cells
(1 time)
CSC (1 time)
HIF-2alpha (1 time)
p-mTOR (1 time)
2020 HIF-2alpha regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling.
18  proteins abundances of AKT
(1 time)
Cell Biology
(1 time)
ADSCs (1 time)
mRNA (1 time)
qRT-PCR (1 time)
2020 The potential role of stromal cell-derived factor-1alpha/CXCR4/CXCR7 axis in adipose-derived mesenchymal stem cells.
19  PTEN and phosphorylation of AKT
(1 time)
Molecular Biology
(1 time)
3-BrPA (1 time)
NSCLC (1 time)
TRIM59 (1 time)
2020 TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.